NICO Corporation received the European CE Mark for its BrainPath brain access system that helps neurosurgeons works on lesions in the subcortical space. It is designed to pass by the brain’s folds without causing too much damage thanks to its atraumatic tip that pushes apart the folds to gently slide through. Once the device reaches its destination, it is removed while a sheath that sits around the device remains in place creating an opening for surgical access.
From NICO’s announcement:
The approach integrates a combination of patented technologies to achieve non-disruptive access, automated tissue removal or clot evacuation, and intraoperative tumor tissue collection and preservation.
Using an opening the size of a dime, BrainPath is uniquely designed to gently displace brain tissue as it creates a corridor to the tumor or hemorrhage site. There is no other technology on the market that integrates imaging and intervention and allows for guided atraumatic access within the brain using a trans-sulcal, parafascicular surgical approach.
The growing body of clinical data for BrainPath procedures continues to demonstrate its overall safety and performance and that it can be used anywhere in the brain’s white matter where access is a challenge.
BrainPath is intended for subcortical access, with specific indications that may include: primary and secondary brain tumors such as glioblastoma, vascular abnormalities that cause intracerebral hemorrhage (ICH) or hemorrhagic stroke and secondary bleeds, and intraventricular tumors or cysts.
The technology has been included in 34 peer-reviewed publications, posters and abstracts and more than 50 presentations at national and international neurosurgical conferences.